Results 161 to 170 of about 357,374 (264)

Renal clear cell carcinoma with co-existing tumor thrombosis of renal vein and ureter: a case report and review of the literature. [PDF]

Front Oncol
Li Q, Sun S, Wang Y, Liu Y, Sun Y.
europepmc   +1 more source

Surgical intervention for renal cell carcinoma with inferior vena cava extension combined with laparoscopic procedure

, 2017
Toshio Kamimura,1 Kazutaka Kida,1 Masashi Takeda,1 Shunsuke Sato,1 Masato Fujii,1 Masahiro Inoue,1 Hiromasa Tsukino,1 Shoichiro Mukai,1 Atsushi Nanashima,2 Kunihide Nakamura,2 Toshiyuki Kamoto1 1Department of Urology, Faculty of Medicine, University of ...
Kamoto T, Takeda M, Sato S, Nakamura K, Mukai S, Kida K, Nanashima A, Inoue M, Fujii M, Kamimura T, Tsukino H   +10 more
core  

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Early onset renal cell carcinoma on the rise. [PDF]

Proc (Bayl Univ Med Cent)
Kimbrough C.
europepmc   +1 more source

Role of everolimus in the treatment of renal cell carcinoma

, 2009
Saby George1, Ronald M Bukowski21University of Texas Health Sciences Center, MC-8221, Division of Hematology and Oncology, San Antonio, Texas, USA; 2CCF Lerner College of Medicine Division of Hematology and Oncology, Cleveland, Ohio, USAAbstract: The ...
Saby George, Ronald M Bukowski
core  

A dose‐finding population pharmacokinetic/pharmacodynamic model of ginisortamab, an anti‐gremlin‐1 monoclonal antibody, in patients with solid tumours

British Journal of Clinical Pharmacology, EarlyView.
Aims Ginisortamab, a first‐in‐class human monoclonal antibody for the treatment of advanced solid tumours, binds to gremlin‐1 and restores bone morphogenetic protein signalling. We used pharmacokinetic/pharmacodynamic (PK/PD) modelling to characterize the relationship between ginisortamab dose and serum gremlin‐1 binding, using model‐based simulations ...
Yin Cheong Wong, Luisa Rojas Chavarro, Paul Jones, David Egging, Wanchana Ungphakorn, Marta Valle, Ivan Matthews   +6 more
wiley   +1 more source

Papillary Renal Neoplasm with Reversed Polarity in a 64-Year-Old Male: A Rare Case Report and Review of the Literature. [PDF]

Int Med Case Rep J
Wang Y, Zhang M, Su G, Zhou Q.
europepmc   +1 more source

Interaction between cellular retinoic acid-binding protein II and histone hypoacetylation in renal cell carcinoma

, 2008
Renal cell carcinoma is a rare but serious malignancy. Since a reduction in the level of retinoic acid receptor beta 2 (RARbeta2) expression in cancer cells due in part to histone hypoacetylation which is controlled by histone deacetylase (HD), the study
Viroj Wiwanitkit, Wiwanitkit, Viroj
core  

Theranostic nanoplatform for high‐performance dual‐modal magnetic resonance imaging‐guided therapy of orthotopic hepatocellular carcinoma

BMEMat, EarlyView.
This article introduces a biomimetic Mn‐doped polydopamine nanoplatform (HAMM NPs) coated with cancer cell membranes. It enables targeted hepatocellular carcinoma theranostics via T1/T2 dual‐mode magnetic resonance imaging and tumor microenvironment‐triggered sonodynamic therapy/chemodynamic therapy, achieving potent antitumor efficacy in subcutaneous ...
Jiayin Lin, Wenbo Chen, Xiuqi Hou, Kai Wang, Fan Liu, Ruling Zhang, Zhong Cao, Jian Zheng   +7 more
wiley   +1 more source

Insights from a rare case of eosinophilic solid and cystic renal cell carcinoma: Diagnostic highlights and therapeutic directions. [PDF]

Urol Case Rep
Qiu J, Ni L, Yu L, Yang Y.
europepmc   +1 more source